Cushing's ulcer: Further reflections

William J Kemp1, Asif Bashir2, Haitham Dababneh2

  • 1Department of Neurological Surgery, Goodman Campbell Brain and Spine, Indiana University School of Medicine, Indianapolis, IN, USA.

Insights

Increased intracranial pressure from brain injuries can overstimulate the vagus nerve, leading to Cushing's ulcers. Harvey Cushing's research highlights this connection between neurological conditions and gastrointestinal issues.

Area of Science:

  • Neurology
  • Gastroenterology
  • Medical History

Background:

  • Intracranial processes like brain tumors and head injuries can elevate intracranial pressure.
  • Elevated intracranial pressure may lead to vagus nerve overstimulation.
  • This overstimulation can increase gastric acid secretion, resulting in Cushing's ulcers.

Purpose of the Study:

  • To review Dr. Harvey Cushing's patient records and literature on gastro-duodenal ulcers.
  • To understand Cushing's perspective on the phenomenon by examining unreported cases.
  • To investigate the link between neurological conditions and ulcer formation.

Main Methods:

  • Review of original patient records from Dr. Harvey Cushing's practice.
  • Analysis of available medical literature on gastro-duodenal ulcers.
  • Examination of clinical records of patients not previously reported by Cushing.

Main Results:

  • Cushing's Yale Registry demonstrated that brain tumors or lesions can disrupt neural pathways, causing gastroduodenal ulceration.
  • Cushing hypothesized that posterior fossa cerebellar operations could lead to ulcers via brain stem disturbances.
  • The study links intracranial lesions to gastrointestinal complications.

Conclusions:

  • Harvey Cushing's foundational work provides a basis for further research into the neurological pathways of ulcer formation.
  • The Yale registry is a significant resource for understanding Cushing's ulcers.
  • Continued research is needed to fully elucidate the mechanisms involved.
Abstract

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
33
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.1K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.9K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
840
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K